1. Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin
by Rosy Dabas, Kareem Jamani, Shahbal B. Kangarloo, Poonam Dharmani-Khan, Tyler S. Williamson, Samar Ousia, Caylib Durand, Don Morris, Douglas Mahoney, Lynn Savoie, Ahsan Chaudhry, Victor H. Jimenez-Zepeda, Faisal M. Khan, Andrew Daly, and Jan Storek
BloodAdv
Volume 3(9):
May 14, 2019
© 2019 by The American Society of Hematology

2. Rosy Dabas et al. Blood Adv 2019;3:1394-1405
© 2019 by The American Society of Hematology

3. CIR in patients with low (below median) vs high pre-HCT AUC of ATG capable of binding to CD33+ cells (top) or MNCs (bottom).
CIR in patients with low (below median) vs high pre-HCT AUC of ATG capable of binding to CD33+cells (top) or MNCs (bottom).
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

4. CIR in patients with low (below median) vs high post-HCT AUC of ATG capable of binding to lymphocytes.
CIR in patients with low (below median) vs high post-HCT AUC of ATG capable of binding to lymphocytes.
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

5. CI of aGVHD (grade 2-4) in patients with low (below median) vs high post-HCT AUC of ATG capable of binding to lymphocytes, T cells, CD4 T cells, or MNCs.
CI of aGVHD (grade 2-4) in patients with low (below median) vs high post-HCT AUC of ATG capable of binding to lymphocytes, T cells, CD4 T cells, or MNCs.
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

6. CI of cGVHD (moderate to severe) in patients with low (below median) vs high post-HCT AUC of ATG capable of binding to MNCs, lymphocytes, or CD33 cells.
CI of cGVHD (moderate to severe) in patients with low (below median) vs high post-HCT AUC of ATG capable of binding to MNCs, lymphocytes, or CD33 cells.
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

7. Scatter plots of pre- (triangle) or post-AUC (circle) of MNC-binding ATG vs the day of neutrophil (top) or platelet (bottom) engraftment.
Scatter plots of pre- (triangle) or post-AUC (circle) of MNC-binding ATG vs the day of neutrophil (top) or platelet (bottom) engraftment. The correlation between pre-AUC and neutrophil engraftment (P = .005) was significant, and the correlation between pre-AUC and platelet engraftment (P = .055) was near significant. There was no significant correlation between post-AUC and neutrophil or platelet engraftment.
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

8. RFS, cGRFS, and OS in patients with low (below median) vs high pre-HCT AUC of MNC-binding ATG.
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

9. Summary of the effects of pre- and post-HCT ATG AUCs on clinical outcomes.
Rosy Dabas et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology